FSCN1 and breast cancer: Thus, the reduction of Slug and fascin protein levels in the miR-30a–transduced breast cancer cells was abrogated upon transfection with the miR-30a inhibitor (anti-miR-30a), which resulted in enhanced tumor cell invasion as compared with control oligonucleotide–transfected cells (Figure 4A–4B).